What Has Been the Growth Trajectory of the Serum Free Media Market?
The serum free media market has seen considerable growth due to a variety of factors.
•In recent times, there's been a swift expansion in the serum-free media market. On track to escalate from $1.6 billion in 2024 to $1.77 billion in 2025, it's expecting a compound annual growth rate (CAGR) of 10.9%.
The historical development in this market can be linked to factors such as improvements in cell culture techniques, regulatory limitations, rising demand for biopharmaceuticals, and lowered risk of contamination.
What Does the Future Hold for the Serum Free Media Market?
The serum free media market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size of serum free media is projected to experience a swift acceleration, reaching a value of $2.83 billion in 2029, fuelled by a compound annual growth rate (CAGR) of 12.4%.
This growth during the forecast period can be credited to facets such as the expansion in bioprocessing, advancements in cell therapy, supportive regulatory framework, stem cell research, and the escalating demand for vaccine production. Some of the emerging trends during this forecast period encompass technological innovation, adoption of animal component-free solutions, bespoke media formulations, microcarrier culture systems, and persistent bioprocessing.
What Are The Leading Drivers Of Growth In The Serum Free Media Market?
The escalating incidence of long-term diseases is projected to stimulate the expansion of the serum-free media market in the future. These chronic conditions often persist for over a year, need constant medical attention, limit regular activities, or a combination of these. Serum-free media is beneficial to scientists as it enables them to tailor the media to suit the particular type of cell being studied, ensuring optimal growth conditions. Moreover, scientists employ serum-free media to cultivate cell types or execute specific applications serum-free, aiding in the creation of new cures and treatments for ongoing illnesses. For instance, in January 2023, the US-based National Library of Medicine, the National Center for Biotechnology Information (NCBI), forecasted that the number of individuals aged 50 years and older suffering from at least one chronic disease is expected to increase by 99.5%, climbing from 71.522 million in 2020 to 142.66 million by 2050. Thus, the rising occurrences of chronic illnesses are fueling the progression of the serum-free media market.
How Are The Segments Defined Within The Global Serum Free Media Market?
The serum free media market covered in this report is segmented –
1) By Media Type: Chinese Hamster Ovary (CHO) Cell Media, Protein Expression Media, Immunology Media, Insect Cell Media, Hybridoma Media, Stem Cell Media, Chemically Defined Media
2) By Application: Biopharmaceutical Production, Tissue Engineering And Regenerative Medicine
3) By End-User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Centers, Other End-Users
Subsegments:
1) By Chinese Hamster Ovary (CHO) Cell Media: CHO-S Media, CHO-DG44 Media
2) By Protein Expression Media: E. coli Expression Media, Yeast Expression Media
3) By Immunology Media: T Cell Media, B Cell Media
4) By Insect Cell Media: Sf9 Media, Sf21 Media
5) By Hybridoma Media: Hybridoma Growth Media, Selection Media
6) By Stem Cell Media: Embryonic Stem Cell Media, Adult Stem Cell Media
7) By Chemically Defined Media: Custom Formulations, Pre-Defined Formulations
Pre-Book The Serum Free Media Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Serum Free Media Market?
Leading corporations in the serum-free media market are striving to create unique products, like advanced CAR T-cell manufacture solutions, to assist progress in cell therapy and cancer treatment. CAR T-cell manufacture pertains to the manipulation of a patient's T-cells (an immune cell type) to display a chimeric antigen receptor (CAR) which specifically identifies cancer cells. For example, Lonza, a pharmaceutical firm in Switzerland, released TheraPEAK T-VIVO Cell Culture Medium in May 2023. This proficient serum-free medium, intended for the cultivation and preservation of various immune cells, especially CAR T-cell manufacturing, is distinct due to its chemically detailed formulation which is not derived from serum or animal sources (NAO), leading to a significant reduction in variability and enhanced consistency in T-cell culture procedures.
Who Are the Key Players in the Serum Free Media Market?
Major companies operating in the serum free media market include:
• Thermo Fisher Scientific Inc.
• Danaher Corp.
• Merck KgaA
• FUJIFILM Irvine Scientific Inc.
• GE HealthCare Technologies Inc.
• Corning Inc.
• Lonza Group AG
• Illumina Inc.
• Cytiva
• Sigma-Aldrich
• Bio-Techne Corporation
• Serumwerk Bernburg AG
• STEMCELL Technologies Inc.
• MP Bio medicals LLC
• Gemcell Electrical Group.
• InVitria Inc.
• Takara Bio Inc.
• HiMedia Laboratories Pvt. Ltd.
• PAA Laboratories GmbH
• PromoCell GmbH
• Cellgenix Gmbh
• Biochrom AG
• Biological Industries
• Pan Biotech GmbH
• Biowest SAS
• Bovogen Biologicals Pty Ltd
• Athena Environmental Sciences Inc.
• Cell Culture Technologies LLC.
• BioSpherix Ltd.
• ZenBio Inc.
What Is The Most Dominant Region In The Serum Free Media Market?
North America was the largest region in the serum-free media market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the serum free media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
